SOURCE: Polaris International Holdings, Inc.
PLANO, TX--(Marketwired - Mar 19, 2014) - Polaris International Holdings, Inc. (PINKSHEETS: PIHN) (OTC Pink: PIHN) is pleased to announce they have entered into an exclusive agreement with Longevity Holdings, LLC for the ProCannas® product line. The agreement grants the sole rights to sell, distribute and market the provisional patent-pending formulation of Longevity Holding, LLC cannabis oil. The ProCannas® line is unique due to the blend of cannabinoids, vitamins, antioxidants, and other proven ingredients to be used for medicinal purposes. The full ProCannas® Line will include liquid drops for ingestion, tablets, and transdermal patches. The oils used in these formulations are high quality pharmaceutical grade and will only be available through licensed participating physicians.
Extensive Research has been conducted in order to arrive at this unique formulation which is void of THC and other psychotropic components. Many independent studies have shown that various formulations of cannabinoids help to prevent cancer and promote overall health without the need for THC. Such formulations are being used regularly in India and date back over 5,000 years as part of Eastern Medicine disciplines.
Safe Harbor Statement:
This news release includes forward-looking statements pertaining to future anticipated projected plans, performance and developments, intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Any statements on this news release that are not statements of historical fact should be considered forward-looking statements. These forward-looking statements generally can be identified by phrases such as "believes," "expects," "anticipates," "foresees," "forecasts," "estimates," "intends," or other words or phrases of similar import. Similarly, statements in this news release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.